About: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $21.25 (-1.51%)
NAMS NASDAQ NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares share price
NAMS price activity
Last Price
$21.250
Change (24hr)
-0.33 USD (-1.51%)
Volume
812.29K
Volume (4w avg)
-
Open
$21.28
Day Range
$21.25 - $21.28
Previous Close
$21.58
Last Trade
12 Oct, 8:16 pm GMT+0
Delayed
12 Oct, 8:16 pm GMT+0
NAMS price performance
Delayed
12 Oct, 8:16 pm GMT+0
NAMS Market Signals